Russell Frank Company’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Russell Frank Company’s Portfolio FLXN Stock Details FLXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$59K	Buy	+6,400	New	+$77.6K	﹤0.01%	2846
2015 Q4	–	Sell	-28,562	Closed	-$424K	–	3064
2015 Q3	$424K	Buy	+28,562	New	+$670K	﹤0.01%	2523
2015 Q2	–	Sell	-34,003	Closed	-$766K	–	3107
2015 Q1	$766K	Buy	+34,003	New	+$787K	﹤0.01%	2272

Other funds holding FLXN

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Russell Frank Company's FLXN Position: Q1 2016 in Review

Russell Frank Company opened a new position in Flexion Therapeutics, Inc. (FLXN) in Q1 2016: 6,400 shares worth $59K. The stake represents ﹤0.01% of the portfolio and ranks #2846 among its holdings. This is a return to the name: Russell Frank Company previously reported a position in FLXN as recently as Q3 2015.

Russell Frank Company first reported a position in FLXN in Q1 2015 and has held it in 3 quarters since. The position peaked at $766K in Q1 2015. 65 funds tracked by Wall St. Rank hold FLXN as of Q1 2016.

Russell Frank Company held 6,400 shares of Flexion Therapeutics, Inc. worth $59K as of Q1 2016.
Flexion Therapeutics, Inc. was a new Russell Frank Company position in Q1 2016.
Flexion Therapeutics, Inc. made up ﹤0.01% of Russell Frank Company's portfolio in Q1 2016, its #2846 holding.
Russell Frank Company first reported a position in Flexion Therapeutics, Inc. in Q1 2015 and has held it in 3 quarters since.
Russell Frank Company's Flexion Therapeutics, Inc. position peaked at $766K in Q1 2015.
65 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.